Detection of clinically relevant early genomic lesions in B‐cell malignancies from circulating tumour DNA using a single hybridisation‐based next generation sequencing assay
- 7 September 2017
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 183 (1), 146-149
- https://doi.org/10.1111/bjh.14919
Abstract
No abstract availableKeywords
Funding Information
- Snowdome Foundation
This publication has 6 references indexed in Scilit:
- Monitoring multiple myeloma by quantification of recurrent mutations in serumHaematologica, 2017
- Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myelomaLeukemia, 2016
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaNature Communications, 2015
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupJournal of Clinical Oncology, 2015
- Secondary abnormalities involving 1q or 13q and poor outcome in high stage Burkitt leukemia/lymphoma cases with 8q24 rearrangement at diagnosisInternational Journal of Hematology, 2011
- Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphomaAnnals Of Oncology, 1997